Jeffrey del Carmen - 19 Aug 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Commercial Officer
Signature
/s/ Jeffrey Del Carmen
Issuer symbol
CPRX
Transactions as of
19 Aug 2022
Net transactions value
+$198,667
Form type
4
Filing time
22 Aug 2022, 17:00:46 UTC
Previous filing
30 Jun 2022
Next filing
15 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale $198,667 +14,140 $14.05 0 19 Aug 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold in various lots from $14.00 to $14.23 per share. The listed sales price represents a weighted average price for the shares sold.
F2 Shares were sold for personal reasons, and does not relate to any disagreements with the Company. Mr. Del Carmen remains an officer of the Company.